Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Correspondence
  • Published:

Authors' reply: Communicating evidence-based practice in menopause

Nature Reviews Disease Primers volume 1, Article number: 15032 (2015) Cite this article

Subjects

Access through your institution
Buy or subscribe

We appreciate the concerns raised by Dr Prior in her correspondence on our Primer (Menopause. Nat. Rev. Dis. Primers 1, 15004 (2015))1, which raised some interesting points (Perimenopause and menopause as oestrogen deficiency while ignoring progesterone. Nat. Rev. Dis. Primers http://dx.doi.org/10.1038/nrdp.2015.31 (2015))2.

The selection of menopause as a topic in this journal highlights the importance of this life phase for women. We were required to format our article according to specific journal guidelines, but this should not to be interpreted as ‘medicalizing menopause’. Rather, our enthusiasm to communicate evidence-based practice to the readership counterbalanced the concern about casting menopause as a disease state. It is difficult to compose a review that encompasses such a large part of a woman's life and that addresses the short-term and chronic conditions arising from menopause, while highlighting the nuances between the menopausal transition and the postmenopausal years.

This is a preview of subscription content, access via your institution

Access options

Access through your institution

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Davis, S. R. et al. Menopause. Nat. Rev. Dis. Primers 1, 15004 (2015).

    Article  Google Scholar 

  2. Prior, J. C. Perimenopause and menopause as oestrogen deficiency while ignoring progesterone. Nat. Rev. Dis. Primers http://dx.doi.org/10.1038/nrdp.2015.31 (2015).

  3. Hitchcock, C. L. & Prior, J. C. Oral micronized progesterone for vasomotor symptoms — a placebo-controlled randomized trial in healthy postmenopausal women. Menopause 19, 886–893 (2012).

    Article  Google Scholar 

  4. U.S. Department of Health and Human Services. Guidance for Industry. Estrogen and estrogen/progestin drug products to treat vasomotor symptoms and vulvar and vaginal atrophy symptoms — recommendations for clinical evaluation. FDA[online], (2003).

  5. Shargil, A. A. Hormone replacement therapy in perimenopausal women with a triphasic contraceptive compound: a three-year prospective study. Int. J. Fertil. 30, 15–28 (1985).

    CAS  PubMed  Google Scholar 

  6. Casper, R. F., Dodin, S. & Reid, R. The effect of 20 mcg ethinyl estradiol/1 gm norethindrone acetate (Minestrin™), a low-dose oral contraceptive, on vaginal bleeding patterns, hot flashes, and quality of life in symptomatic periomenopausal women. Menopause 4, 139–147 (1997).

    Article  Google Scholar 

  7. Santoro, N. et al. Use of a levonorgestrel-containing IUS with supplemental estrogen improves symptoms in perimenoapusal women — a pilot study. Menopause (in the press).

  8. Hampton, N. R. et al. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women. Hum. Reprod. 20, 2653–2660 (2005).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. School of Public Health and Preventive Medicine, Monash University, 99 Commercial Road, Melbourne, 3004, Victoria, Australia

    Susan R. Davis

  2. University of Colorado School of Medicine, Aurora, Colorado, USA

    Nanette Santoro

  3. Medical School, University of Athens, and Aretaieio University Hospital, Athens, Greece

    Irene Lambrinoudaki

  4. Reproductive & Maternal Medicine, Glasgow Royal Infirmary, Glasgow, UK

    Maryann Lumsden

  5. School of Population Health, Faculty of Medicine and Biomedical Sciences, University of Queensland, Queensland, Australia

    Gita D. Mishra

  6. Department of Obstetrics, Gynecology & Reproductive Sciences, Yale University School of Medicine, New Haven, Connecticut, USA

    Lubna Pal

  7. Women's Centre, John Radcliffe Hospital, Oxford, UK

    Margaret Rees

  8. University of Pisa, Pisa, Italy

    Tommaso Simoncini

Authors
  1. Susan R. Davis
    View author publications

    Search author on:PubMed Google Scholar

  2. Nanette Santoro
    View author publications

    Search author on:PubMed Google Scholar

  3. Irene Lambrinoudaki
    View author publications

    Search author on:PubMed Google Scholar

  4. Maryann Lumsden
    View author publications

    Search author on:PubMed Google Scholar

  5. Gita D. Mishra
    View author publications

    Search author on:PubMed Google Scholar

  6. Lubna Pal
    View author publications

    Search author on:PubMed Google Scholar

  7. Margaret Rees
    View author publications

    Search author on:PubMed Google Scholar

  8. Tommaso Simoncini
    View author publications

    Search author on:PubMed Google Scholar

Corresponding author

Correspondence to Susan R. Davis.

Ethics declarations

Competing interests

S.R.D. has received honoraria from Abbott Pharmaceuticals and is an investigator for Trimel Pharmaceuticals and Lawley Pharmaceuticals; all other authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Davis, S., Santoro, N., Lambrinoudaki, I. et al. Authors' reply: Communicating evidence-based practice in menopause. Nat Rev Dis Primers 1, 15032 (2015). https://doi.org/10.1038/nrdp.2015.32

Download citation

  • Published:

  • DOI: https://doi.org/10.1038/nrdp.2015.32

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing